|
1981 |
Incorporated NATCO Pharma Division at Kothur, Mahaboobnagar Dist, Andhra Pradesh, India |
|
1984 |
First full year in Operations - sales Rs. 0.5 million |
|
1986 |
Inaugurated Parenterals Manufacturing facility at Nagarjunasagar, India |
|
1993 |
Inaugurated NATCO Chemical Division at Mekaguda, Mahaboobnagar Dist, Andhra Pradesh, India |
|
1995 |
Merged three of the group companies with the parent Company. Natco Pharma Limited was granted US Patent for its manufacturing process of Omeprazole |
|
1997 |
Inaugurated NATCO Research Center(NRC) at Sanathnagar, Hyderabad, India |
|
2003 |
Launched Oncology division with introduction of flagship brand VEENAT (generic Imatinib Mesylate) for the treatment of chronic myelogenous leukemia |
|
2006 |
Inaugurated NATCO Pharma Division at Dehradun, India |
|
2008 |
NATCO filed its first Paragraph IV filing in the US market |
|
2009 |
Inaugurated NATCO Organics at Chennai, India, with facilities dedicated for Cyto-toxic APIS’s and Biotechnology products NATCO’s turnover reached $100 million |
|
2011 |
NATCO and Levomed LLC, USA formed a Joint Venture company, NATCOFARMA DO BRASIL for sales and distribution in Brazil |
